⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TRDA News
Entrada Therapeutics, Inc. Common Stock
Terradepth’s Absolute Ocean Cleared for Immediate U.S. Navy Use via NIWC Atlantic RCC Hopper
businesswire.com
TRDA
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TRDA
Form 8-K
sec.gov
TRDA
Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
TRDA
Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
globenewswire.com
TRDA
Entrada Therapeutics to Present at Upcoming Investor Conferences
globenewswire.com
TRDA
Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases
globenewswire.com
TRDA
Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
TRDA
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TRDA
Entrada Therapeutics Reports Third Quarter 2025 Financial Results
globenewswire.com
TRDA